CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 863335449
- Phone
- 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $44,939
- in 3 filings, $45K under 10b5-1 plans
Net −$44,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-14 | Lang Eric Chief Medical Officer | Grant or award · Stock Option | +130,000 | 154,223 | ||
| 2024-06-14 | Friedberg Ezra M Director | Grant or award · Restricted Stock Units | +64,498 | 610,219 | ||
| 2024-06-14 | Malamut Richard Director | Grant or award · Restricted Stock Units | +64,498 | 81,165 | ||
| 2024-06-14 | Francis Knuettel II CEO, Pres., CFO Treas & Secty | Grant or award · Stock Options | +27,778 | 52,778 | ||
| 2024-06-14 | Francis Knuettel II CEO, Pres., CFO Treas & Secty | Grant or award · Stock Options | +324,000 | 376,778 | ||
| 2024-06-14 | Davis Todd C Director | Grant or award · Restricted Stock Units | +128,977 | 213,701 | ||
| 2024-02-21 | Francis Knuettel II CEO, Pres., CFO Treas & Secty | Grant or award · Employee Stock Option | +2,778 | 25,001 | ||
| 2024-02-21 | Friedberg Ezra M Director | Purchase | +16,667 | $6.00 | $100K | 545,721 |
| 2024-02-21 | Francis Knuettel II Interim CEO, CFO Treas & Secty | Grant or award · Employee Stock Option | −2,778 | 25,001 | ||
| 2024-02-21 | Davis Todd C Director | Option exercise | +29,167 | $4.80 | $140K | 29,167 |
| 2024-02-21 | Davis Todd C Director | Conversion · Secured Convertible Promissory Note | −0 | 0 | ||
| 2024-02-21 | Friedberg Ezra M Director | Option exercise | +13,649 | $4.80 | $66K | 513,727 |
| 2024-02-21 | Friedberg Ezra M Director | Option exercise | +6,992 | $4.80 | $34K | 520,719 |
| 2024-02-21 | Friedberg Ezra M Director | Conversion · Secured Convertible Promissory Note | −65,513.61 | 0 | ||
| 2024-02-21 | Friedberg Ezra M Director | Conversion · Secured Convertible Promissory Note | −33,136 | 0 |
Page 6 of 6 · 115 trades